Opening book details…
Can I read Proteasome Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development) on EtoBox?
Proteasome Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development) by Julian Adams is a nonfiction available to read on EtoBox.
What is Proteasome Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development) about?
A panel of leading academic and pharmaceutical investigators takes stock of the remarkable work that has been accomplished to date with proteasome inhibitors in cancer, and examines emerging therapeutic possibilities. The topics range from a discussion of the chemistry and cell biology of the proteasome and the rationale for proteasome inhibitors in cancer to a review of current clinical trials underway. The discussion of rationales for testing proteasome inhibitors in cancer models covers the role of the proteasome in NF-kB activation, the combining of conventional chemotherapy and radiation with proteasome inhibition, notably PS-341, new proteasome methods of inhibiting viral maturation, and the role of protesome inhibition in the treatment of AIDS. The authors also document the development of bortezomib (VelcadeTM) in Phase I clinical trials and in a multicentered Phase II clinical trials in patients with relapsed and refractory myeloma.
Who reads Proteasome Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)?
It is typically read by self-directed learners exploring a subject in depth.
Common subject areas: history, science, philosophy, social sciences.
- Author
- Julian Adams
- Publisher
- Totowa, N.J.: Humana Press
- Published
- 2004
- Language
- EN
- ISBN
- 9781617374524
- Category
- nonfiction
- Subjects
- Medical, Nursing, Medicine
More by Julian Adams
Browse all works by Julian Adams
Similar books
- STAT Inhibitors in Cancer (Cancer Drug Discovery and Development) — Alister C. Ward (2016)
- PARP Inhibitors for Cancer Therapy (Cancer Drug Discovery and Development) — Nicola J. Curtin, Ricky A. Sharma (2015)
- COX-2 Blockade in Cancer Prevention and Therapy (Cancer Drug Discovery and Development) (Cancer Drug Discovery and Development) — Rashida A. Karmali JD PhD (auth.), Randall E. Harris MD, (2003)
- Tumor Targeting In Cancer Therapy (cancer Drug Discovery And Development) — Tarunendu Ghose (auth.), Michel Pagé PhD (2002)
- Death Receptors in Cancer Therapy (Cancer Drug Discovery and Development) — E. Robert McDonald III PhD, Wafik S. El-Deiry MD, PhD (auth.), (2005)
- Regional Cancer Therapy (Cancer Drug Discovery and Development) — Ulrike S. Stein PhD, Wolfgang Walther PhD, Peter M. Schlag MD, PhD (auth.), Peter M. Schlag MD, Ulrike Stein PhD, Alexander M. Eggermont (2007)